In the second part of a recent interview, Nina Kottler, M.D., M.S., discussed keys to evaluating the potential value of artificial intelligence (AI) systems and emerging developments with AI that were discussed at the recent Radiological Society of North America (RSNA) conference.
In the current health care climate, return on investment (ROI) may be the most paramount consideration in choosing and implementing an artificial intelligence (AI) system into a radiology practice or hospital.
With declining reimbursements and increasing costs of care, Nina Kottler, M.D., M.S. emphasized that hospitals and radiology practices don’t have extra dollars to invest in technology. In a recent interview, Dr. Kottler noted the combination of increasing imaging volume and radiologist shortages continue to exacerbate the challenges.
“(There are) not enough people coming out of residency to hire our way out of this problem. We need to innovate our way out of this problem,” maintained Dr. Kottler, the associate chief medical officer of Clinical AI and vice-president of Clinical Operations at Radiology Partners.
The continued emergence of literature documenting the diagnostic capabilities and improved efficiencies with AI-powered systems can facilitate improved patient outcomes, allow for more diagnostic exams and treatment interventions to be performed, according to Dr. Kottler. She added that a number of positive developments coming out of the recent Radiological Society of North America (RSNA) conference continue to build the emerging ROI case for AI in radiology.
At the RSNA conference, Dr. Kottler said it was clear that more and more radiologists are recognizing AI “as something they need to do, not just a nice to have.” She emphasized that robust improvements in AI, fueled by engineering-based and cloud-based technology, can facilitate implementation into radiology workflows. Dr. Kottler added that an increased emphasis on AI standards for vendors will allow more of a “plug and play” transition with AI systems as opposed to the current daunting approach of trying to integrate the technology into various aspects of existing systems and workflows at radiology practices and hospital facilities.
(Editor’s note: For related content, see “Recognizing and Addressing Biases with AI and Radiologists,” “Emerging Concepts and Perspectives in Radiology: Video Interviews from RSNA 2022” and “Assessing and Implementing Artificial Intelligence in Radiology.”)
As more radiologists and facilitates incorporate AI systems, Dr. Kottler says the increased experience with implementation will hopefully lead to best practice standards for initial and ongoing evaluations of AI models.
For more insights from Dr. Kottler, watch the video below.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
SNMMI: Can Multimodal Monitoring Bolster Outcomes with Pluvicto in Treating mCRPC?
June 22nd 2025Multimodal treatment monitoring, including SPECT/CT exams 24 hours after treatment with Lu-177 PSMA-617, may have facilitated significantly shorter therapy durations and reduced side effects in patients with mCRPC, according to a two-year study presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.